TCI Wealth Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11
Closed -$3K 1575
2023
Q1
$3K Buy
+11
New +$4.04K ﹤0.01% 1851
2022
Q4
Sell
-14
Closed -$3K 2607
2022
Q3
$3K Hold
14
﹤0.01% 1809
2022
Q2
$3K Buy
14
+8
+133% +$3.44K ﹤0.01% 1852
2022
Q1
$4K Hold
6
﹤0.01% 1753
2021
Q4
$4K Hold
6
﹤0.01% 1864
2021
Q3
$5K Buy
6
+3
+100% +$2.04K ﹤0.01% 1626
2021
Q2
$2K Buy
3
+2
+200% +$1.53K ﹤0.01% 2057
2021
Q1
$1K Hold
1
﹤0.01% 2096
2020
Q4
$1K Hold
1
﹤0.01% 1423
2020
Q3
$1K Buy
+1
New +$821 ﹤0.01% 1381

Other funds holding OM

TCI Wealth Advisors's OM Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Outset Medical (OM) in Q2 2023, closing a stake of 11 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in OM in Q3 2020 and held it in 10 quarters. The position peaked at $5K in Q3 2021. 154 funds tracked by Wall St. Rank hold OM as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Outset Medical position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 11 Outset Medical shares in Q2 2023, an estimated $3K.
  • TCI Wealth Advisors first reported a position in Outset Medical in Q3 2020 and held it in 10 quarters.
  • TCI Wealth Advisors's Outset Medical position peaked at $5K in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Outset Medical as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.